Orchestra BioMed
OBIO
OBIO
39 hedge funds and large institutions have $121M invested in Orchestra BioMed in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 42 → 39 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.27M | |
| 2 | +$968K | |
| 3 | +$356K | |
| 4 |
Morgan Stanley
New York
|
+$313K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$199K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$172K | |
| 3 | -$110K | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$72.4K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$42.8K |